Recently , men with intermediate-risk prostate cancer ( PC ) were classified into favorable and unfavorable categories ; however , whether the risk of PC-specific mortality ( PCSM ) among men with high-risk PC versus unfavorable intermediate-risk PC is increased is unknown .